SSc is clinically and aetiopathogenically heterogeneous. Consensus standards for more uniform trial design and selection of outcome measures are needed. The objective of this study was to develop evidence-based points to consider (PTCs) for future clinical trials in SSc.

Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards

CUTOLO, MAURIZIO;
2015-01-01

Abstract

SSc is clinically and aetiopathogenically heterogeneous. Consensus standards for more uniform trial design and selection of outcome measures are needed. The objective of this study was to develop evidence-based points to consider (PTCs) for future clinical trials in SSc.
File in questo prodotto:
File Dimensione Formato  
Twenty-two points.pdf

accesso chiuso

Tipologia: Documento in versione editoriale
Dimensione 127.86 kB
Formato Adobe PDF
127.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/812648
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 26
social impact